http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113491272-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-07 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-08 |
filingDate | 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113491272-B |
titleOfInvention | Application of flavonoid glycoside compound in resisting tobacco mosaic virus and preparation method thereof |
abstract | The invention discloses application of flavonoid glycoside compounds in resisting tobacco mosaic virus and a preparation method thereof, wherein the three compounds are kaempferol-3-O-alpha-rhamnoside, isovitexin 6' -O-E-p-coumaric acid and quercetin-3-O-beta-glucuronic acid respectively, and the three compounds can be used for resisting the tobacco mosaic virus. Experiments show that the passivation effect of the three compounds on TMV is better than that of the commercial medicament ningnanmycin, and the systemic resistance effect of the compound II on TMV on common tobacco is better than that of ningnanmycin, so that the three compounds have good passivation, protection and treatment effects on TMV and can be used as plant antiviral agents and plant immunity inducing agents. |
priorityDate | 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.